Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 410 News Items found Vaccine Targeting KRAS in Pancreatic and Colorectal Cancer Shows Promise Monday, August 11, 2025 Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning. Dormant Cancer Cells Change Shape To Survive Immune System Attack Thursday, January 15, 2026 New MSK research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape. Feature The Future of Cancer Research: Five Reasons for Optimism Tuesday, May 10, 2016 Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer. Fighting Cancer With Computers, Math, and Artificial Intelligence Saturday, July 1, 2023 MSK Drs. Larry Norton, Dana Pe’er, and Sohrab Shah know cancer research isn’t all beakers and test tubes — computers and algorithms are some of the most powerful tools in cancer research. Q&A Metastatic and Metastasized Cancers: Answers to 7 Common Questions Tuesday, July 26, 2022 In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK. In the Clinic Treating Brain Cancer with Radiation Plus Immunotherapy: A Successful Synergy? Tuesday, September 27, 2016 MSK’s Kathryn Beal presents new findings on combining radiation with immunotherapy for brain cancer. Feature Top Cancer Treatment Advances at MSK in 2023 Monday, December 18, 2023 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2023. Read about some of the most important developments over the past year. Does Eating Soy Increase Estrogen and Cause Breast Cancer? Wednesday, July 27, 2022 Learn whether eating soy products causes cancer. Q&A Preventing Nausea and Vomiting after Cancer Treatment: 7 Questions with an MSK Expert Monday, July 31, 2017 Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer. FDA Approves Zenocutuzumab for Cholangiocarcinoma Based on MSK-Led Trial Wednesday, July 8, 2026 The FDA has approved zenocutuzumab (Bizengri®) for adults with advanced, unresectable, or metastatic cholangiocarcinoma driven by a molecular change called an NRG1 gene fusion, based on a trial led by an MSK investigator. Pagination First page « First Previous page ‹ Previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment